A Consensus Molecular Classification of Muscle-invasive Bladder Cancer

Muscle-invasive bladder cancer (MIBC) is a molecularly diverse disease with heterogeneous clinical outcomes. Several molecular classifications have been proposed, but the diversity of their subtype sets impedes their clinical application. To achieve an international consensus on MIBC molecular subty...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European urology Jg. 77; H. 4; S. 420 - 433
Hauptverfasser:	Kamoun, Aurélie, de Reyniès, Aurélien, Allory, Yves, Sjödahl, Gottfrid, Robertson, A. Gordon, Seiler, Roland, Hoadley, Katherine A., Groeneveld, Clarice S., Al-Ahmadie, Hikmat, Choi, Woonyoung, Castro, Mauro A.A., Fontugne, Jacqueline, Eriksson, Pontus, Mo, Qianxing, Kardos, Jordan, Zlotta, Alexandre, Hartmann, Arndt, Dinney, Colin P., Bellmunt, Joaquim, Powles, Thomas, Malats, Núria, Chan, Keith S., Kim, William Y., McConkey, David J., Black, Peter C., Dyrskjøt, Lars, Höglund, Mattias, Lerner, Seth P., Real, Francisco X., Radvanyi, François, Aine, Mattias, Bernard-Pierrot, Isabelle, Czerniak, Bogdan, Gibb, Ewan A., Kim, Jaegil, Kwiatkowski, David J., Lebret, Thierry, Liedberg, Fredrik, Siefker-Radtke, Arlene, Sirab, Nanor, Taber, Ann, Weinstein, John
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Switzerland Elsevier B.V 01.04.2020 Elsevier
Schlagworte:	Basic Medicine Cancer and Oncology Cancer och onkologi Clinical Medicine Consensus Klinisk medicin Life Sciences Medical and Health Sciences Medical Genetics and Genomics (including Gene Therapy) Medicin och hälsovetenskap Medicinsk genetik och genomik (Här ingår: Genterapi) Medicinska och farmaceutiska grundvetenskaper Molecular taxonomy Muscle-invasive bladder cancer Transcriptomic classifier Transcriptomic classifier Muscle-invasive bladder cancer Consensus Molecular taxonomy
ISSN:	0302-2838, 1873-7560, 1421-993X, 1873-7560, 1421-993X
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!